Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?

Journal of Hypertension- Open Access
doi 10.4172/2167-1095.1000e101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Angiotensin Converting Enzyme (ACE) Inhibitor

Journal of Nihon University Medical Association
2014English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy